Humana Q1 2026 earnings beat estimates, stock falls

Humana reported first-quarter adjusted net per stock of $10.31, topping expert estimates of $10.19, according to Reuters. Despite the beat, Humana banal fell arsenic overmuch arsenic 7% successful premarket trading earlier paring losses.

At 89.4%, Humana's security conception payment ratio — which measures what information of premium gross goes toward aesculapian attraction — edged retired the company's ain people of conscionable nether 90%. The institution noted that trends successful some aesculapian and pharmacy costs were coming successful somewhat much favorably than it had anticipated.

Revenue for the 4th reached $39.6 billion, up from $32.1 cardinal successful the aforesaid play a twelvemonth earlier. GAAP diluted net per stock were $9.83, compared with $10.30 successful Q1 2025.

Humana affirmed its full-year adjusted nett forecast of astatine slightest $9 per stock but lowered its GAAP net forecast to astatine slightest $8.36 from a anterior estimation of astatine slightest $8.89. The institution said it expects second-quarter security conception payment ratio to travel successful somewhat supra 91%, a deterioration from the archetypal quarter.

The determination to clasp guidance steady, alternatively than rise it arsenic immoderate rivals person done, appeared to disappoint investors. "Investors whitethorn person been disappointed that Humana did not summation its outlook for 2026 fixed its beardown commencement to the year," Morningstar expert Julie Utterback told Bloomberg. Cantor expert Sarah James told Reuters that signals astir the backmost fractional of the twelvemonth "could beryllium hard to manage."

Rechtin told investors that portion existent utilization and spending person tracked expectations, national reimbursement has failed to support pace, leaving a larger shortfall than the institution faced a twelvemonth ago. "Every twelvemonth we're going to measurement backmost and look astatine our full portfolio," Rechtin told Reuters. "The applicable world is, each product, if priced appropriately, is bully product." Humana said it volition set benefits arsenic indispensable to support profitability.

Humana stood by its earlier projection that enrollment successful its idiosyncratic Medicare Advantage plans would grow astir 25% implicit the people of 2026. Total Medicare Advantage rank stood astatine astir 7.1 cardinal arsenic of March 31, up from astir 5.8 cardinal a twelvemonth earlier. Humana holds astir 18% of the Medicare Advantage market, according to Yahoo Finance.

Operating costs successful the CenterWell segment, which provides superior attraction to older adults, came successful supra Wall Street's expectations. The segment's operating outgo ratio roseate to 94.5% from 91.1% a twelvemonth earlier, the institution said. For Humana overall, the quarterly operating outgo ratio landed astatine 10.2%, good supra the statement expert forecast of 9.5%, according to Bloomberg.

A 2.48% mean summation successful national Medicare Advantage outgo rates for 2027, announced by the U.S. government, falls abbreviated of what Humana says it needs to screen escalating costs.